Can the observed association between serum perfluoroalkyl substances and delayed menarche be explained on the basis of puberty-related changes in physiology and pharmacokinetics?

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Environment International

• Publication date

  2015-09-01

• Fields of study

  Medicine, Chemistry, Environmental Science

• Identifiers
  DOI 10.1016/j.envint.2015.05.006PMID 26043300
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Phthalate exposure and pubertal development in a longitudinal study of US girls.

  2014cited by this paper
• Pubertal Growth and Serum Testosterone and Estradiol Levels in Boys

  2013cited by this paper
• Uterine secretomics: a window on the maternal-embryo interface.

  2013cited by this paper
• Is the Relationship between Prenatal Exposure to PCB-153 and Decreased Birth Weight Attributable to Pharmacokinetics?

  2013cited by this paper
• S-078: Use of Physiologically-based Pharmacokinetic Models to Evaluate Epidemiologic Associations that may be Due to Reverse Causality

  2012cited by this paper
• Relationships of Perfluorooctanoate and Perfluorooctane Sulfonate Serum Concentrations between Mother–Child Pairs in a Population with Perfluorooctanoate Exposure from Drinking Water

  2012cited by this paper
• Evaluation and prediction of pharmacokinetics of PFOA and PFOS in the monkey and human using a PBPK model.

  2011cited by this paper
• Association of Perfluorooctanoic Acid (PFOA) and Perfluorooctane Sulfonate (PFOS) with age of puberty among children living near a chemical plant.

  2011cited by this paper
• Serum PBDEs and age at menarche in adolescent girls: analysis of the National Health and Nutrition Examination Survey 2003-2004.

  2011cited by this paper
• Polyfluorinated compounds: past, present, and future.

  2011cited by this paper
• Investigation on per- and polyfluorinated compounds in paired samples of house dust and indoor air from Norwegian homes.

  2011cited by this paper
• Environmental fate and transport modeling for perfluorooctanoic acid emitted from the Washington Works Facility in West Virginia.

  2011cited by this paper
• Trends in exposure to polyfluoroalkyl chemicals in the U.S. Population: 1999-2008.

  2011cited by this paper
• Levels of perfluorinated compounds in food and dietary intake of PFOS and PFOA in the Netherlands.

  2010cited by this paper
• Tissue distribution of (35)S-labelled perfluorooctane sulfonate (PFOS) in C57Bl/6 mice following late gestational exposure.

  2010cited by this paper
• The C8 Health Project: Design, Methods, and Participants

  2009cited by this paper
• Rate of Decline in Serum PFOA Concentrations after Granular Activated Carbon Filtration at Two Public Water Systems in Ohio and West Virginia

  2009cited by this paper
• Perfluorooctanoic Acid (PFOA) and Pubertal Maturation in Young Girls

  2009cited by this paper
• Studies on the Toxicological Effects of PFOA and PFOS on Rats Using Histological Observation and Chemical Analysis

  2009cited by this paper
• Development and specification of physiologically based pharmacokinetic models for use in risk assessment.

  2008cited by this paper
• Perfluoroalkyl acids: a review of monitoring and toxicological findings.

  2007cited by this paper
• Tissue distribution and hepatic subcellular distribution of perfluorooctanoic acid at low dose are different from those at high dose in rats.

  2007cited by this paper
• A Methodology for Estimating Human Exposure to Perfluorooctanoic Acid (PFOA): A Retrospective Exposure Assessment of a Community (1951–2003)

  2006cited by this paper
• Gestational PFOA exposure of mice is associated with altered mammary gland development in dams and female offspring.

  2006cited by this paper
• Exposure assessment and risk characterization for perfluorooctanoate in selected consumer articles.

  2005cited by this paper
• The reproductive toxicology of ammonium perfluorooctanoate (APFO) in the rat.

  2004cited by this paper
• Body mass index is associated with altered renal hemodynamics in non-obese healthy subjects.

  2004cited by this paper
• Evaluation of the potential impact of age- and gender-specific pharmacokinetic differences on tissue dosimetry.

  2004cited by this paper
• Quantification of menstrual blood loss

  2004cited by this paper
• Estimating Menstrual Blood Loss in Women With Normal and Excessive Menstrual Fluid Volume

  2001cited by this paper
• Evaluation of the Uncertainty in an Oral Reference Dose for Methylmercury Due to Interindividual Variability in Pharmacokinetics

  1999cited by this paper
• Body mass index and height from childhood to adulthood in the 1958 British born cohort.

  1997cited by this paper
• A longitudinal assessment of hormonal and physical alterations during normal puberty in boys. II. Estrogen levels as determined by an ultrasensitive bioassay.

  1996cited by this paper
• Human uterine fluid, examined in undiluted samples for osmolarity and the concentrations of inorganic ions, albumin, glucose, and urea.

  1984cited by this paper

• A Human Next Generation PBK Model for PFOA

  2026cites this paper
• Association between Perfluoroalkyl and Polyfluoroalkyl Substances Exposure and Reproductive Longevity for Female in the United States: A Population-Based Study.

  2026cites this paper
• Associations between prenatal and adolescent per- and polyfluoroalkyl substances (PFAS) exposure and pubertal development as well as endocrine hormones in girls from the Sheyang Mini Birth Cohort.

  2026cites this paper
• Prenatal and prepubertal exposures to organochlorine compounds and perfluoroalkyl substances and pubertal development at age 12: The PELAGIE cohort study.

  2025cites this paper
• Exposure to Per- and Polyfluoroalkyl Substances (PFAS) and Timing of Menarche: A Systematic Review and Meta-Analysis.

  2025cites this paper
• In vitro and computational approaches to predict developmental toxicity: Integrating PBPK models with cell-based assays.

  2025cites this paper
• Associations of maternal per- and polyfluoroalkyl substance plasma concentrations during pregnancy with offspring polycystic ovary syndrome and related characteristics in Project Viva.

  2025cites this paper
• Socio-demographic inequalities influence differences in the chemical exposome among Swedish adolescents.

  2024cites this paper
• Use of quantitative in vitro to in vivo extrapolation (QIVIVE) for the assessment of non-combustible next-generation product aerosols

  2024cites this paper
• Chemical exposomics in biobanked plasma samples and associations with breast cancer risk factors

  2024cites this paper
• A Comprehensive Library of Lifetime Physiological Equations for PBK Models: Enhancing Dietary Exposure Modeling with Mercury as a Case Study.

  2024influential citation
• Reliability of toxicokinetic modelling for PFAS exposure assessment in contaminated water in northern Italy

  2024cites this paper
• Are Chinese mitten crabs (Eriocheir sinensis) suitable as biomonitor or bioindicator of per- and polyfluoroalkyl substances (PFAS) pollution?

  2023cites this paper
• Low concentrations of perfluoroalkyl acids (PFAAs) in municipal drinking water associated with serum PFAA concentrations in Swedish adolescents.

  2023cites this paper
• PFAS and Phthalate/DINCH Exposure in Association with Age at Menarche in Teenagers of the HBM4EU Aligned Studies

  2023cites this paper
• A State-of-the-Science Review of Interactions of Per- and Polyfluoroalkyl Substances (PFAS) with Renal Transporters in Health and Disease: Implications for Population Variability in PFAS Toxicokinetics

  2023cites this paper
• Associations of prenatal and postnatal exposure to perfluoroalkyl substances with pubertal development and reproductive hormones in females and males: The HOME study.

  2023cites this paper
• Association of perfluoroalkyl and polyfluoroalkyl substances with sex hormones in children and adolescents 6-19 Years of age.

  2023cites this paper
• Demographic, life-style and physiological determinants of serum per- and polyfluoroalkyl substance (PFAS) concentrations in a national cross-sectional survey of Swedish adolescents.

  2022cites this paper
• Household low pile carpet usage was associated with increased serum PFAS concentrations in 2005-2006.

  2021cites this paper
• Development of a Gestational and Lactational Physiologically Based Pharmacokinetic (PBPK) Model for Perfluorooctane Sulfonate (PFOS) in Rats and Humans and Its Implications in the Derivation of Health-Based Toxicity Values

  2021cites this paper
• Prospective associations of mid-childhood plasma per- and polyfluoroalkyl substances and pubertal timing.

  2021cites this paper
• Using quantitative modeling tools to assess pharmacokinetic bias in epidemiological studies showing associations between biomarkers and health outcomes at low exposures.

  2021cites this paper
• The concentration of several perfluoroalkyl acids in serum appears to be reduced by dietary fiber

  2020cites this paper
• Determinants of serum concentrations of perfluoroalkyl acids (PFAAs) in school children and the contribution of low-level PFAA-contaminated drinking water.

  2020cites this paper
• Pharmacokinetic bias analysis of an association between clinical thyroid disease and two perfluoroalkyl substances.

  2020cites this paper
• Perfluoroalkyl and polyfluoroalkyl substances (PFAS) and their effects on the ovary

  2020cites this paper
• Association between per and polyfluoroalkyl substances and markers of inflammation and oxidative stress.

  2020cites this paper
• Using BMI as a chronometer for persistent chemical exposures and chronic disease.

  2020cites this paper
• Interspecies differences in perfluoroalkyl substances (PFAS) toxicokinetics and application to health-based criteria.

  2019cites this paper
• Ontogeny equations with probability distributions for anthropomorphic measurements in preterm and term neonates and infants for use in a PBPK model

  2019cites this paper
• Determinants of serum perfluoroalkyl acid concentrations in Swedish adolescents and the importance of drinking water as a source of exposure

  2019cites this paper
• Quantitative bias analysis of the association between subclinical thyroid disease and two perfluoroalkyl substances in a single study.

  2019cites this paper
• Development and Application of a Life-Stage Physiologically Based Pharmacokinetic (PBPK) Model to the Assessment of Internal Dose of Pyrethroids in Humans

  2019cites this paper
• Exposure Assessment to Environmental Pollutants in Human Health Risk Assessment Studies; Overview on New Approaches

  2019cites this paper
• Predicting the pharmacokinetics of piperacillin and tazobactam in preterm and term neonates using physiologically based pharmacokinetic modeling

  2019cites this paper
• Perfluorooctanoate and changes in anthropometric parameters with age in young girls in the Greater Cincinnati and San Francisco Bay Area.

  2019cites this paper
• Exploring sex differences in human health risk assessment for PFNA and PFDA using a PBPK model

  2018cites this paper
• Biomonitoring of perfluorinated compounds in adults exposed to contaminated drinking water in the Veneto Region, Italy.

  2018cites this paper
• Risk to human health related to the presence of perfluorooctane sulfonic acid and perfluorooctanoic acid in food

  2018cites this paper
• Perfluoroalkyl acids in serum of Korean children: Occurrences, related sources, and associated health outcomes.

  2018cites this paper
• Sex-specific risk assessment of PFHxS using a physiologically based pharmacokinetic model

  2017cites this paper
• Predictors of Per- and Polyfluoroalkyl Substance (PFAS) Plasma Concentrations in 6-10 Year Old American Children.

  2017cites this paper
• Quantitative bias analysis of a reported association between perfluoroalkyl substances (PFAS) and endometriosis: The influence of oral contraceptive use.

  2017cites this paper
• Quantitative bias analysis for epidemiological associations of perfluoroalkyl substance serum concentrations and early onset of menopause.

  2017influential citation
• Perfluoroalkyl Substances, Sex Hormones, and Insulin-like Growth Factor-1 at 6–9 Years of Age: A Cross-Sectional Analysis within the C8 Health Project

  2016cites this paper
• A Study of Reverse Causation: Examining the Associations of Perfluorooctanoic Acid Serum Levels with Two Outcomes

  2016cites this paper
• Perfluorooctane Sulfonate Induces Autophagy-Dependent Apoptosis through Spinster 1-Mediated lysosomal-Mitochondrial Axis and Impaired Mitophagy.

  2016influential citation
• ehp Perfluoroalkyl Substances , Sex Hormones , and Insulin-like Growth Factor-1 at 6 – 9 Years of Age : A Cross-Sectional Analysis within the C 8 Health Project

  2016cites this paper
• Addressing Early Life Sensitivity Using Physiologically Based Pharmacokinetic Modeling and In Vitro to In Vivo Extrapolation

  2016cites this paper
• Pharmacokinetic bias analysis of the epidemiological associations between serum polybrominated diphenyl ether (BDE-47) and timing of menarche.

  2016cites this paper